Clene Inc. (CLNN)

NASDAQ: CLNN · USD

$4.02

+0.05 (+1.3%)· Recorded snapshot

Market cap	57.1M
Revenue (ttm)	197K
Net income (ttm)	-39.5M
EPS (ttm)	-$3.50
Shares out	14.2M
Volume	40,356
Beta	0.92

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 197K
Net income (ttm): -39.5M
EPS (ttm): -$3.50
Market cap: 57.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-260.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CLNN indicators

Market & fundamental data

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001822791
Company name	Clene Inc.
Country	United States
Country code	US
CUSIP number	185634201
Earnings date	2026-11-12
Earnings time	bmo
Employees	79
Employees change	3
Employees growth	3.95%
Enterprise value	$69.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US1856342019
Last 10-K release date	2026-03-17
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2024-07-11
Last stock split type	Reverse
Market cap	$57.1M
Market cap category	Micro-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$4.02
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CLNN
U.S. state	Utah
Website	https://clene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-87.16%
EV/Sales	350.77x
FCF / EV yield	-23.08%
FCF yield	-28.26%
Forward EV/Sales	285.08x
Forward P/S	232.79x
P/S ratio	286.44x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	70.05%
Operating margin	-10,431.98%
Pretax margin	-20,059.9%
Profit per employee	$-500,228
Revenue per employee	$2,494
ROA	-56.88%
ROA (5Y)	-54.31%
ROCE	-112.99%
ROIC	-260.46%
SBC / revenue	2,751.27%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Gross profit growth	-40%
Gross profit growth (Q)	100%
Gross profit growth 3Y	-41.43%
Net income growth years	2
Revenue growth	-31.12%
Revenue growth (Q)	233.33%
Revenue growth (QoQ)	500%
Revenue growth 3Y	-36.9%
Revenue growth 5Y	-18.29%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-40,000
Depreciation and amortization	$1.4M
EBIT	$-20.6M
EBITDA	$-19.1M
EPS	$-3.50
FCF per share	$-1.12
Financing cash flow	$18.3M
Free cash flow	$-15.9M
Free cash flow minus SBC	$-21.4M
Gross profit	$138,000
Investing cash flow	$-40,000
Net borrowing	$1.1M
Net cash flow	$2.4M
Net income	$-39.5M
Operating cash flow minus SBC	$-21.3M
Operating income	$-20.6M
Revenue	$197,000
Stock-based compensation	$5.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-21.61
Book value per share	$-1.94
Interest coverage	-7.13
Long-term assets	$8.1M
Long-term liabilities	$43M
Net cash (debt)	$-12.7M
Net cash / market cap	-22.46%
Piotroski F-Score	2
Property, plant and equipment	$8.1M
Shareholders' equity	$-24.8M
Tangible book value	$-24.8M
Tangible book value per share	$-1.94
Total assets	$23M
Total cash	$9.7M
Total debt	$22.3M
Total liabilities	$47.8M
WACC	9.55%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.01
Current assets	$14.9M
Current liabilities	$4.9M
Current ratio	3.07
Inventory turnover	1.02
Net working capital	$1.6M
Quick ratio	2.24
Working capital	$10.1M
Working capital turnover	0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-35.38%
Dividend yield	0%
Shareholder yield	-35.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$5.25
1D price change	1.26%
1M price change	-6.51%
1M total return	-6.51%
1W price change	6.92%
1W total return	6.92%
1Y price change	-52.76%
1Y return CAGR	-52.79%
1Y total return	-52.76%
20-day SMA	$3.74
200-day SMA	$5.20
3M price change	-26.37%
3M total return	-26.37%
3Y price change	-51.74%
3Y return CAGR	-21.56%
3Y total return	-51.74%
50-day SMA	$3.97
50-day SMA vs 200-day SMA	50under200
52-week high	$13.50
52-week high date	2025-11-03
52-week low	$3.02
52-week low date	2026-10-16
5Y price change	-96.4%
5Y return CAGR	-48.58%
5Y total return	-96.4%
6M price change	-33.66%
6M total return	-33.66%
All-time high	$356.40
All-time high date	2021-07-13
All-time low	$2.28
All-time low date	2025-05-23
Average true range (ATR)	$0.29
Average volume	94.1K
Beta (1Y)	2.55
Beta (2Y)	1.96
Beta (5Y)	0.92
Change from 52-week high	-70.22%
Change from 52-week low	33.33%
Change from all-time high	-98.87%
Change from all-time low	76.32%
Change from open	-0.74%
Day's gap	2.02%
Dollar volume	$162,231
High price	$4.05
Low price	$4.02
Monthly RSI	38.91
Open price	$4.05
Position in 52-week range	0%
Previous close	$3.97
Price vs 150-day SMA	-23.49%
Price vs 20-day SMA	7.63%
Price vs 200-day SMA	-22.62%
Price vs 50-day SMA	1.34%
Relative volume	0.43
RSI	55.57
Sharpe ratio	-0.3
Sharpe ratio (3Y)	0.2
Sharpe ratio (5Y)	-0.19
Sortino ratio	-0.37
Sortino ratio (3Y)	0.38
Sortino ratio (5Y)	-0.23
Volume	40.4K
Weekly RSI	43.98
YTD price change	-31.52%
YTD total return	-31.52%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11.6M
Float percentage	81.96%
Shares change (QoQ)	6.34%
Shares change (YoY)	35.38%
Shares held by insiders	11.27%
Shares held by institutions	24.06%
Shares outstanding	14.2M
Short % of float	3.65%
Short % of shares	2.99%
Short ratio	6.2 days

Deeper analysis on CLNN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CLNN report

Is a complete CLNN research report available?

No complete published report is available for Clene Inc. (CLNN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Clene Inc. (CLNN)

Price

Financial snapshot

Fair-value bridge

Latest news · CLNN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLNN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CLNN

Frequently asked questions